share_log

Merck & Co | POSASR: Post-effective amendment to an automatic shelf registration statement on Form S-3ASR or Form F-3ASR

Merck & Co | POSASR: Post-effective amendment to an automatic shelf registration statement on Form S-3ASR or Form F-3ASR

默沙东 | POSASR：注册声明修正稿
美股SEC公告 ·  05/15 11:35
Moomoo AI 已提取核心信息
Merck & Co., Inc. (Merck), known as MSD outside the United States and Canada, has filed a post-effective amendment to a registration statement with the U.S. Securities and Exchange Commission (SEC) on May 14, 2024. The amendment pertains to the registration of debt securities by both Merck and its wholly-owned subsidiary, MSD Netherlands Capital B.V. (MSD Netherlands). The registration statement includes an indenture between Merck and U.S. Bank Trust National Association, serving as trustee, and a similar indenture between MSD Netherlands, Merck, and the trustee. These documents govern the issuance of the debt securities, which are unsecured and may be offered in various transactions at fixed or variable prices. The securities may be sold through underwriters, dealers, agents, or directly to investors. Merck's filing ensures compliance with federal securities laws and provides legal frameworks for potential future debt offerings by both Merck and MSD Netherlands.
Merck & Co., Inc. (Merck), known as MSD outside the United States and Canada, has filed a post-effective amendment to a registration statement with the U.S. Securities and Exchange Commission (SEC) on May 14, 2024. The amendment pertains to the registration of debt securities by both Merck and its wholly-owned subsidiary, MSD Netherlands Capital B.V. (MSD Netherlands). The registration statement includes an indenture between Merck and U.S. Bank Trust National Association, serving as trustee, and a similar indenture between MSD Netherlands, Merck, and the trustee. These documents govern the issuance of the debt securities, which are unsecured and may be offered in various transactions at fixed or variable prices. The securities may be sold through underwriters, dealers, agents, or directly to investors. Merck's filing ensures compliance with federal securities laws and provides legal frameworks for potential future debt offerings by both Merck and MSD Netherlands.
默沙东公司（Merck）（在美国和加拿大以外被称为默沙东）已于2024年5月14日向美国证券交易委员会（SEC）提交了注册声明的生效后修订。该修订涉及默沙东及其全资子公司默沙东荷兰资本有限公司（MSD 荷兰）的债务证券注册。注册声明包括默沙东与作为受托人的美国银行信托全国协会之间的契约，以及默沙东荷兰、默沙东和受托人之间的类似契约。这些文件管理债务证券的发行，债务证券是无抵押的，可以在各种交易中以固定或可变价格发行。证券可以通过承销商、交易商、代理人出售，也可以直接出售给投资者。默沙东的文件确保遵守联邦证券法，并为默沙东和荷兰默沙东未来可能的债务发行提供法律框架。
默沙东公司（Merck）（在美国和加拿大以外被称为默沙东）已于2024年5月14日向美国证券交易委员会（SEC）提交了注册声明的生效后修订。该修订涉及默沙东及其全资子公司默沙东荷兰资本有限公司（MSD 荷兰）的债务证券注册。注册声明包括默沙东与作为受托人的美国银行信托全国协会之间的契约，以及默沙东荷兰、默沙东和受托人之间的类似契约。这些文件管理债务证券的发行，债务证券是无抵押的，可以在各种交易中以固定或可变价格发行。证券可以通过承销商、交易商、代理人出售，也可以直接出售给投资者。默沙东的文件确保遵守联邦证券法，并为默沙东和荷兰默沙东未来可能的债务发行提供法律框架。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

独立文件3  查看翻译

独立文件4  查看翻译

独立文件5  查看翻译

独立文件6  查看翻译

独立文件7  查看翻译

独立文件8  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息